Search

Cerebral revascularization is constantly being updated and iterated, but there are still many challenges: how to regulate the bypass flow quantitatively, how to reconstruct cerebral artery perforator vessels with diameter less than 0.5 mm, etc.. This paper reviews the birth of revascularization and the development of cerebral revascularization, focusing on the basic principle and innovative technology of cerebral revascularization, application and effect of cerebral revascularization in the treatment of complex intracranial aneurysms, current situation and development trend of cerebral revascularization iteration. The aim is to promote the iteration of cerebral revascularization and its application in the treatment of complex intracranial aneurysms.

Deep brain stimulation (DBS) has been widely used for Parkinson's disease, essential tremor, dystonia, drug - resistant epilepsy and other diseases. The operation procedure of this surgical method is complicated, and it also has certain complications in clinical application, including surgical complications such as intracranial hemorrhage and infection, hardware complications such as lead fracture and displacement, and stimulation complications such as paresthesia and muscle spasm, in which lead fracture and erosion and infection of the skin behind the ear are common and troublesome complications. In clinical practice, we found that lead fracture and erosion and infection of the skin were mainly located behind the ear. Since 2012, Beijing Tiantan Hospital, Capital Medical University had applied the retroauricular bone grinding groove technology in DBS, which significantly reduced the incidence of lead fracture and erosion and infection of the skin. Therefore, the retroauricular bone grinding groove technology can effectively solve the above problems. This paper mainly introduces the retroauricular bone grinding groove technology and the clinical application attention matters, providing references for colleagues.

Neurosurgical critical care is playing an increasingly pivotal role in the advancement of neurosurgery. It not only provides perioperative life support for neurosurgical patients but also addresses the treatment of severe cerebrovascular diseases and traumatic brain injury. Over the past two decades, major tertiary hospitals in China have established subspecialties dedicated to neurosurgical critical care. However, at the county level and other grassroots hospitals, the adoption of neurosurgical critical care concepts require further promotion. This paper reviews the development history of the neurosurgical critical care specialty and proposes measures to enhance the diagnostic and treatment capabilities of grassroots hospitals. These measures include standardizing core professional competencies, implementing high-quality multi - disciplinary team, and improving essential hardware configurations, with the goal of achieving standardized diagnosis and treatment in neurosurgical critical care.

摘要： 酒精使用所致障碍作为全球第五大风险因素，是卒中预防的重要内容。近年来大量流行病学和临床研究显示，酒精使用与卒中之间存在相关性，酒精可通过多种途径影响心脑血管健康，从而引发卒中甚至死亡。同时也有研究显示，酒精使用与卒中之间或许存在不同的关联性，轻度饮酒可能是心脑血管的保护因素，中重度饮酒可能会诱发、加重卒中。本文分析了卒中合并酒精使用所致障碍的流行现状，对酒精使用所致障碍影响卒中发病的可能机制进行综述，同时总结了酒精摄入监测生物标志物和酒精使用所致障碍的治疗方式，以期进一步探讨卒中与酒精使用所致障碍之间的相关性，为临床诊疗提供思路。 Abstract: Alcohol use disorder, as the fifth largest risk factor worldwide, is an important component of stroke prevention. In recent years, a large number of epidemiological and clinical studies have shown that there is a correlation between alcohol and stroke. Alcohol can affect cardiovascular and cerebrovascular health through various ways, resulting in stroke and even death. At the same time, some studies have shown that there may be different associations between alcohol and stroke, light drinking may be a cardiovascular and cerebrovascular protective factor, and moderate and heavy drinking may induce and aggravate stroke. This paper analyzed the current prevalence of stroke complicated with alcohol use disorder, reviewed the possible pathogenesis of alcohol use disorder affecting the incidence of stroke, and summarized alcohol intake monitoring biomarkers and treatments related to alcohol use disorder, in order to further explore the correlation between stroke and alcohol use disorder and provide ideas for clinical diagnosis and treatment.

Postural disorder is a common disabling movement complication of Parkinson's disease (PD), in which camptocormia is the most common disabling postural disorder, which further aggravates the movement disorder of PD, and seriously reduces the activities of daily living and quality of life of patients. This paper reviews the pathogenesis and treatment progress of PD with camptocormia, providing theoretical basis for further investigation of the pathogenesis of camptocormia in PD, and assisting the clinical diagnosis and treatment of the disease.

Gait disorder is one of common motor symptoms in patients with Parkinson's disease (PD), significantly affecting their quality of life and mobility. Robot ‑ assisted gait training (RAGT) can improve the motor symptoms of PD patients, particularly in terms of lower limb motor function. It corrects abnormal spatiotemporal parameters of gait, such as gait velocity, step length, and step frequency, reduces the occurrence of freezing of gait, improves endurance, enhances balance ability, and ultimately improves quality of life. This paper focuses on the classification and construction, clinical efficacy and mechanism of exoskeleton robot, which can be used to guide the rehabilitation treatment of PD.

With the aggravation of population aging, the health of the elderly has become an important issue in the aging society. The Mediterranean diet (MD) contributes to healthy aging by changing dietary patterns to delay and prevent disease onset. This paper summarizes the concepts related to the MD pattern and its relationship with cardiovascular diseases, cognitive dysfunction, depression, chronic inflammation and other brain and heart comorbidity in the elderly, so as to provide thinking and reference for the optimization and upgrading of the elderly, and contribute to the development of healthy China.

The heart and brain are important organs of human body, which are closely related in genetic, structural and functional aspects. It is of great significance to elucidate the correlation between heart and brain and its mechanism for prevention and treatment of cardiovascular and cerebrovascular diseases. This paper reviews the genetic, structural and functional correlations between heart and brain, and discusses mechanisms of correlations from the perspective of common clinical heart diseases and brain diseases, so as to provide theoretical basis for the research and treatment of brain and heart comorbidity.

Left ventricular assist devices (LVAD) implantation is an effective treatment for end ⁃ stage heart failure in addition to heart transplantation. Neurological complications, especially ischemic stroke and hemorrhagic stroke, are the most common complications in patients after LVAD. This paper reviews the common neurological complications and its risk factors in patients after LVAD, and proposes early prevention and management strategies to provide guidance for the perioperative and long ⁃ term management of LVAD implantation in end⁃stage heart failure.

Cardiovascular surgery has a high risk of neurological complications, which can increase the burden of disease. Perioperative real⁃time monitoring of neurological function in cardiovascular surgery can assist clinicians to detect neurological abnormalities as early as possible, intervene and reduce the risk of neurological complications in time. The main monitoring indicators include cerebral oxygen saturation (ScO2), EEG, cerebral blood flow (CBF), etc. In this paper, the common perioperative neuromonitoring techniques and their research advances in cardiovascular surgery are reviewed to provide theoretical basis for reducing neurological complications and improve the prognosis of patients.

Spontaneous intracerebral hemorrhage (ICH) is a global public health concern with high mortality and poor functional outcomes. In recent years, some breakthroughs were made in researches on pathophysiology, neuroprotection, prevention and treatment, prognosis and risk of rehemorrhage of ICH. Some research achievements from Chinese scholars have gained attention and recognition around the world. In this paper, advances in ICH research on pathophysiology, neuroprotection, prevention and treatment, prognosis and risk of rehemorrhage will be overviewed based on high?quality overseas papers from Chinese scholars published in recent 5 years. DOI: 10.3969/j.issn.1672-6731.2018.11.003

ObjectiveThis paper summarizes the research progress into stimulation methods used in rehabilitation equipment for pediatric cerebral palsy (CP) for the past 20 years from 2003 to 2023. We also provide ideas for innovative research and development of artificial intelligence-based rehabilitation equipment.MethodsThrough a certain search strategy, Keywords are searched in the China National Knowledge Network Database (CNKI), the Wanfang Database knowledge service platform, the Chongqing VIP information service, PubMed, Web of Science, Cochrane, ScienceDirect, Medline, Embase, and IEEE database. A total of 3,049 relevant articles were retrieved, and 49 articles were included that mentioned research and development of rehabilitation equipment. We excluded articles that were not specific to children with CP, were duplicated or irrelevant literature, were missing data, the full article was not available, the article did not describe the method of stimulation used with the rehabilitation equipment on children with CP, were not Chinese and English, and were the types of reviews and commentaries.ResultsPhysical stimulation is the main stimulation method of rehabilitation equipment for children with CP. Force stimulation is the main mode of physical stimulation, and there are 17 articles that have verified the clinical efficacy of force stimulation-based equipment.ConclusionResearch on the stimulation mode of pediatric cerebral palsy rehabilitation equipment is likely to focus on simulating the force of the Chinese medicine called “tuina manipulation.” When this method is combined with artificial intelligence and personalized direction we believe this will lay the foundation for future development of a novel therapy for children with CP.

Neurophysiological technique uses the bioelectrical principle to record the spontaneous or external stimulation⁃induced electrical activities of the central or peripheral nervous system. Due to the essential difference in the pathophysiological mechanism of functional and organic movement disorders, neurophysiology is of great significance for the diagnosis and differential diagnosis of the central and peripheral nervous systems. In order to improve the understanding of the pathogenesis of functional movement disorder (FMD) and provide the basis for the accurate diagnosis, this paper reviews the common clinical neurophysiological techniques and their application in FMD.

Functional neurological disorder (FND) is a kind of voluntary motor or sensory system disease with definite symptoms. As a kind of nervous system disease which can be included in chronic disease management but not easy to identify, its increasing number of patients and social burden have aroused great attention in society. Based on the author′s clinical practice and thinking on FND in recent years, this paper analyzes how to further strengthen the diagnosis, treatment and management of FND in China, and puts forward relevant countermeasures and suggestions, so as to achieve early detection, early diagnosis and early treatment of diseases, and improve the quality of life of patients.

The circle of Willis constitutes the primary collateral circulation of the brain, exerting a significant influence on the distribution of intracranial blood flow. Variations of the circle of Willis can impact the cerebrovascular diseases by diminishing collateral compensation capacity and altering the stability of intracranial hemodynamics. This paper reviews the research progress on the association between circle of Willis and cerebral large vessel disease [such as intracranial arterial dolichoectasia (IADE) and intracranial atherosclerotic stenosis (ICAS)], as well as cerebral small vessel disease (CSVD), so as to provide new ideas for the diagnosis and treatment for these diseases.

Cerebral small vessel disease (CSVD) is a research hotspot in recent 20 years. In order to standardize the name and definition of the imaging features of CSVD, the STandards for ReportIng Vascular changes on nEuroimaging (STRIVE) recommended the imaging diagnostic criteria for CSVD in 2013, namely STRIVE⁃1. In 2023, this standard updated according to the research achievement in recent 10 years. This paper aims to introduce STRIVE⁃2, especially focus on explaining the differences between these two standards in order to help clinicians and researchers understand the changes.

An accurate diagnosis of consciousness disorder after brain injury is the basis for further treatment. The previous evaluation of consciousness disorder after brain injury is mainly based on behavior scales and imaging examination, which is limited to subjective factors and external interference and difficult to detect and evaluate in real time. The development of objective and efficient evaluation methods of consciousness disorder after brain injury is currently a hot spot in clinical research. Neurophysiological monitoring is safe, objective, simple to operate, and can be detected continuously timely. It can be used as an evaluation method for consciousness disorder after brain injury. In this paper, we summarize the application paradigms and analysis methods of evoked potential and EEG in the clinical evaluation of consciousness disorder after brain injury in recent years, in order to provide new technical ideas for improving the clinical diagnosis and treatment of consciousness disorder after brain injury.

The tumor tissue of craniopharyngioma is closely adherent to peripheral neurovascular tissue, so the operation to remove lesion is more difficult, the perioperative complications are very serious, and the prognosis of patients is poor. There are many studies on the use of tumor histology or anatomical classification to guide surgical principles and surgical approaches, as well as drug therapy or combination therapy, but no consensus has been reached. This paper reviews the histological, anatomical and molecular typing of craniopharyngioma, providing new ideas for the future realization of the fusion typing of craniopharyngioma to guide the precise treatment.

Abstract Background Dementia is generally caused by neurodegenerative diseases affecting the brain, which leads to a progressive neurocognitive decline characterized by inability to perform major higher functioning tasks. Fluorodeoxyglucose-positron emission tomography (FDG-PET) scan is one of the main imaging tests performed for diagnostic purposes. However, with FDG-PET being quite expensive and not widely available, an attempt to find an alternative is set. Arterial-spin-labelling magnetic resonance imaging (ASL-MRI) is an increasingly investigated substitute to FDG-PET for the diagnosis of dementia. Thereby, the main purpose of this systematic review and meta-analysis is to compare the diagnostic ability of FDG-PET and ASL-MRI in detecting dementia. Methods PRISMA checklist for diagnostic test accuracy was employed in outlining this paper. A literature search was done using several search engines including PubMed, Core, and Cochrane. Two researchers (HH and SH) extracted the essential information from all included articles. Risk of bias was evaluated by the Quality Assessment of Diagnostic Accuracy Studies tool, version 2 (QUADAS-2). A qualitative analysis and summary of studies’ results were provided. In addition, a meta-analysis was executed based on the studies which involved sensitivity and specificity measures of diagnostic accuracy. Results Fourteen total studies were included in the given review. Qualitative analysis of the articles showed that nine studies demonstrated an overlap between metabolic and perfused brain maps as derived by FDG-PET and ASL-MRI respectively, while the remaining five studies registered significant differences across both modalities, with superiority to FDG-PET. As for the meta-analysis implemented, summary ROC-curve analysis revealed that FDG-PET performed better than ASL-MRI, with pooled sensitivity being significantly higher for FDG-PET. Conclusions Comparing the diagnostic value of FDG-PET and ASL-MRI, the results of this systematic review and meta-analysis indicate that FDG-PET still has an advantage over ASL-MRI. Such implication could be related to the technical differences relating to both modalities, with ASL-MRI having lower temporal resolution. It’s worth mentioning that specificity was rather quite similar among both modalities and some studies found an overridden metabolic and perfused images. These findings call for future research to focus their scope of investigation while exploring the diagnostic value of ASL-MRI.

Recently, both the paper "Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches" in Lancet Neurol and "Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria" in Mov Disord attracted much attention. In this review, we will discuss the contents in these two papers, including disease progression, features of clinical phenotype, update in diagnostic criteria, biomarkers, and therapeutic status and prospect of progressive supranuclear palsy (PSP), to guide the clinical practice. DOI: 10.3969/j.issn.1672-6731.2018.01.001

BackgroundStroke burden is largely due to long-term impairments requiring prolonged care with loss of productivity. We aimed to identify and assess studies of different registered pharmacological therapies as treatments to improve post-stroke impairments and/or disabilities.MethodsWe performed a systematic-search-and-review of treatments that have been investigated as recovery-enhancing or recovery-promoting therapies in adult patients with stroke. The treatment must have received registration or market authorization in any country regardless of primary indication. Outcomes included in the review were neurological impairments and functional/disability assessments. “The best available studies” based on study design, study size, and/or date of publication were selected and graded for level of evidence (LOE) by consensus.ResultsOur systematic search yielded 7,801 citations, and we reviewed 665 full-text papers. Fifty-eight publications were selected as “the best studies” across 25 pharmacological classes: 31 on ischemic stroke, 21 on ischemic or hemorrhagic stroke, 4 on intracerebral hemorrhage, and 2 on subarachnoid hemorrhage (SAH). Twenty-six were systematic reviews/meta-analyses, 29 were randomized clinical trials (RCTs), and three were cohort studies. Only nimodipine for SAH had LOE A of benefit (systematic review and network meta-analysis). Many studies, some of which showed treatment effects, were assessed as LOE C-LD, mainly due to small sample sizes or poor quality. Seven interventions had LOE B-R (systematic review/meta-analysis or RCT) of treatment effects.ConclusionOnly one commercially available treatment has LOE A for routine use in stroke. Further studies of putative neuroprotective drugs as adjunctive treatment to revascularization procedures and more confirmatory trials on recovery-promoting therapies will enhance the certainty of their benefit. The decision on their use must be guided by the clinical profile, neurological impairments, and target outcomes based on the available evidence.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/display_record.php?RecordID=376973, PROSPERO, CRD42022376973.

Cardiovascular and cerebrovascular diseases are the main causes of disability and death, and atherosclerosis is an important cause. The incidence of atherosclerosis in premenopausal women is significantly lower than that in men of the same age, while the incidence of atherosclerosis in postmenopausal women is significantly higher than that in men of the same age, which is closely related to estrogen levels. In this paper, sex differences in atherosclerosis were reviewed from the aspects of imaging examination, risk factors, intestinal microbiome and vascular inflammatory effects on atherosclerosis, to provide evidence for precision medical treatment of atherosclerosis.

小血管疾病在脑血管疾病中占有重要地位，是导致老年人认知能力下降和功能丧失的主要原因。脑小血管病（cerebral small vessel disease，CSVD）是以小血管结构或功能病变所导致的一系列临床、病理和影像学改变为主要表现的综合征，患者常以头晕为主要症状和主诉。近年来，越来越多的研究表明CSVD可导致头晕，但其机制还尚未完全明确。本文就头晕与CSVD的关系及其可能的机制进行综述，旨在为头晕患者发生CSVD的识别和诊治提供一定的参考。 Abstract: Small vessel disease plays an important role in cerebrovascular diseases, which is the main cause of cognitive decline and functional loss in the elderly. Cerebral small vessel disease (CSVD) is a syndrome characterized by a series of clinical, pathological and imaging changes caused by small vascular structural or functional lesions. Some patients often come to hospital with dizziness as the main symptom and complaint. In recent years, more and more studies have shown that CSVD can lead to dizziness, but the mechanism has not been fully explained. This paper reviews the relationship between dizziness and CSVD and its possible related mechanisms, aiming to provide some reference for the identification, diagnosis and treatment of CSVD in patients with dizziness.

Cognitive behavioral therapy for insomnia (CBT ⁃ I) boasts convincing evidence from randomized controlled clinical trials, yet its practical application encounters substantial barriers. This paper analyzes the key techniques and challenges of CBT ⁃I, proposing the following workflow improvements to enhance its clinical application and benefit more insomnia patients.

Idiopathic rapid eye movement sleep behavior disorde (iRBD) is a precursor symptom of neurodegenerative diseases, and most patients will convert to neurodegenerative diseases later in the disease. Reliable biological markers are of great significance for early identification of high⁃risk converters and predicting phenoconversion pattern. This paper reviews the research progress of biological markers in predicting conversion to neurodegenerative diseases in iRBD from clinical symptomology, neuroelectrophysiology, neuroimaging, body fluid, pathology and gene markers, in order to select patients suitable for disease modification therapy and delay the development of neurodegenerative diseases.

The pathogenesis of cerebral small vessel disease (CSVD) is not yet clear, and there is no effective treatment method at present. MRI is an important imaging in diagnosing. In this paper, the imaging markers and scoring methods and criteria of CSVD are elaborated, and the diagnosing and grading methods of CSVD are discussed, to provide theoretical basis for diagnosis and treatment of the disease.

Functional gait disorder (FGD) is a common subtype of functional movement disorder (FMD), mainly characterized by instability, lameness and Parkinson's gait. The clinical manifestations of FGD are the same as those of other types of gait disorder, with the possibility of misdiagnosis. However, there are significant differences in the treatment principles between them, so clear diagnosis and accurate treatment are crucial to improve patients' symptoms and prognosis. This paper aims to systematically review the epidemiological characteristics, clinical manifestations, auxiliary examination, diagnosis and differential diagnosis, treatment and prognosis of FGD, in order to improve the understanding of clinicians.

The article reviews foreign and Russian literature on the organization of headache (HA) treatment. The economic burden of HA has been convincingly proven. The medical aid appealability of patients with HA has been established to be low (20–60%). This is frequently due to a lack of confidence in the success of a doctor's advice. The paper considers various models for the management of patients with HA in foreign countries. There is a low reliability of the diagnosis established during questionnaire surveys. Whether the patients can be managed using telecommunications, such as telephone and online counseling, is described. In Russia, there are substantially fewer treatment options for patients with HA; at the same time the available models are inclined to foreign ones. The paper describes world and Russian practices in educating the physicians and underlines the need for patients with HA to have educational classes. The sites where both the doctor and the patient can receive relevant information about HA are considered.

Cerebral cavernous malformation is the second most common vascular malformation of the central nervous system. The main clinical manifestations in children include epileptic seizure, spontaneous cerebral hemorrhage, and focal neurological deficits. The lesions are mostly single or multiple, most of which were detected incidentally. MRI has a high discrimination of cerebral cavernous malformation and is the imaging modality of choice for it. However, the pathogenesis has not been elucidated and the treatment methods still lack summary. This paper reviews the clinical characteristics and pathogenesis of cerebral cavernous malformation in children, involved clinical characteristics, imaging features, potential pathogenesis and treatment methods, to deepen the understanding of cerebral cavernous malformation for further individual treatment.

Creutzfeldt⁃Jakob disease (CJD) is a group of clinically rare neurodegenerative diseases caused by misfolding of prion proteins, and is the most common type of human prion diseases. Since the prion characteristics were recognized in the 1970s, the diagnostic detection technology has made great progress, especially the real⁃time quaking⁃induced conversion (RT⁃QuIC). This paper describes the pathogenesis of CJD, the mechanism of action of RT⁃QuIC and its application in the diagnosis of CJD in order to promote the application and development of RT⁃QuIC technology in the field of CJD.

Alzheimer's disease (AD) is a common neurological degenerative disease that can cause structural and functional abnormalities of the heart. Amyloid⁃β protein (Aβ) and AD⁃related gene variants play important roles in the pathophysiological changes of the heart associated with AD. This paper reviews the structural and functional damage of the heart associated with AD and its possible mechanism of action, providing theoretical basis for a comprehensive understanding of AD and exploring new drugs and therapeutic targets.

Subjective cognitive decline (SCD) refers to the preclinical stage of Alzheimer's disease (AD) in which patients have the chief complaint of cognitive decline but no objective manifestations. It is considered to be an earlier stage of mild cognitive impairment (MCI) than the preclinical stage of AD, and the risk of progression to AD is higher. At present, there is a limited understanding of SCD in China. This paper reviews the concept of SCD, the status quo of epidemiological research, research framework, related risk factors, its relationship with AD, as well as the progress of neuropsychological tests and imaging research, so as to provide the possibility for the early clinical diagnosis and treatment of AD.

Cognition disorders is a common complication of epilepsy, which seriously affects patients' activities of daily living. Timely measures can avoid further impairment of patients' cognitive function. There are many risk factors for cognition disorders in patients with epilepsy. This paper summarizes the risk factors related to cognition disorders in patients with epilepsy, and classifies them according to epileptic factors and non⁃epileptic factors, so as to provide a theoretical basis for accurate treatment of epilepsy.

Mesenchymal stem cells (MSCs) have great potential in the treatment of ischemic stroke. Because they possess low immunogenicity, high proliferation, and different capabilities. MSCs are mostly derived from bone marrow, adipose tissue, and placenta; they act mainly by regulating immune and inflammatory responses, neuroprotection, and promoting angiogenesis; they can be introduced into the body via intracerebral or intravascular injection, and their efficacy in treating ischemic stroke can be enhanced when combined with physical methods such as hypoxic pretreatment. This paper reviews the animal studies of MSCs treatment of ischemic stroke and describes the therapeutic effects of MSCs on ischemic stroke model animals from the perspectives of the types of MSCs, mechanisms of action, injection methods, and physical methods of intervention to enhance the efficacy of MSCs, to provide new ideas for the clinical treatment of ischemic stroke.

BackgroundPost-stroke fatigue (PSF) is a ubiquitous and overwhelming symptom for most stroke survivors. However, there are no effective management strategies for PSF, which is partly due to our limited understanding.ObjectiveIn this paper, we review the development, prevalence, predisposing factors, measurements, and treatments of PSF.ResultsPSF is an independent symptom after stroke, with a prevalence ranging from 42 to 53%, which depends on the selection of measurement tools and stroke characteristics. It is affected by biological, physical, and psychological factors, among which inflammation may play a key role.ConclusionNumerous but non-specific evaluation measurement tools limit the management of PSF. In clinical practice, it may be beneficial to identify PSF by combining scales and objective indexes, such as walking tests and electromyographic examinations. There are no evidence-based interventions to improve PSF. However, increasing evidence suggests that transcranial direct-current stimulation and mindfulness-based interventions may become promising treatments. Further studies are urgently needed to better understand the etiology of PSF, thereby providing the basis for developing new measurement tools and targeted treatments.

With the rapid development of neuroelectrophysiology, neuroimaging and other technologies, a large amount of evidence has shown the occurrence and development of epilepsy was closely related to cortico⁃subcortical neural network. This paper aims to review the relevant studies on the involvement of subcortical structures such as thalamus, hypothalamus, cerebellum, basal ganglia and brainstem in the occurrence and development of epilepsy, as well as some important targets of subcortical nucleus for the treatment of drug⁃resistant epilepsy (DRE) by neuroregulation, in order to provide help for the exploration of new intervention targets for epilepsy treatment.

7T ultra⁃high field MRI (7T MRI), with its high resolution, high signal⁃to⁃noise ratio (SNR) and high contrast, is superior to conventional field intensity MRI in clinical applications such as diagnosis of hippocampal sclerosis (HS) and focal cortical dysplasia (FCD), assisting in the identification of pathological subtypes of the both, locating the scope of surgical excision, and has made progress in the diagnosis and treatment of drug⁃resistant epilepsy (DRE). This paper aims to review the clinical application value and research progress of 7T MRI in order to promote its application in the field of diagnosis and treatment of epilepsy.

Functional movement disorder (FMD) is a common conversion disorder, and those who involve the face are called functional facial disorders. It seriously affects patients' social contact and work. Most clinicians have insufficient understanding of functional facial disorders, resulting in delayed diagnosis and treatment. This paper reviews the clinical features, electrophysiology, diagnosis and differential diagnosis, and treatment of functional facial disorders to improve the level of diagnosis and treatment.

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive involvement of upper motor neuron (UMN) and lower motor neuron (LMN). With the rapid development of sequencing technique, genetic screening of ALS improved from a single locus site sequencing to whole exome sequencing (WES) or whole genome sequencing (WGS), more and more pathogenic genes affecting the occurrence and development of diseases have been discovered. At present, the pathophysiological mechanisms of ALS mainly include abnormal protein aggregation, abnormal DNA or RNA function, changes in cytoskeleton and axon dynamics, autophagy process, lysosome dysfunction, and mitochondrial dysfunction. Exploring the genetic mechanism of ALS has great significance to elucidate its pathophysiological mechanism. This paper reviews the main pathogenic genes, genetic research methods and related pathogenic mechanisms of ALS, reveals the pathogenesis and development of the disease and related pathophysiological mechanisms, and provides new strategies for the treatment of ALS.

In recent years, with the rapid development of gene sequencing technology, a variety of epilepsy pathogenic genes have been discovered, among which GRIN2A gene variations encoding the neurotransmitter N⁃methyl⁃D⁃aspartate receptor (NMDAR) are closely related to the occurrence of epilepsy. At present, there are relatively few studies on the function of epileptic related variations in GRIN2A gene. The resulting epilepsy phenotypes are complex and varied, and different patients have different therapeutic effects on different drugs. This paper briefly summarizes the possible relationship between the changes of NMDAR structure and function caused by GRIN2A gene variations and the clinical phenotype of epilepsy, providing clues for the precise treatment of epilepsy.

Epilepsy is a common neurological disease in clinic. Epilepsy caused by structural causes can be cured by surgery, which has been the focus of attention in the field of epilepsy surgery. With the development of gene sequencing technology, more and more studies have found that structural etiology may be caused by somatic mutations of genes. In this paper, somatic mutation⁃related pathogenic genes of four common pathological types of epilepsy surgery, including malformation of cortical development (MCD), long⁃term epilepsy associated tumor (LEAT), hippocampal sclerosis (HS) and hypothalamic hamartoma (HH), were reviewed, and their effects on surgical protocol formulation and prognosis were reviewed, in order to provide a new idea for the treatment of epilepsy.

Paroxysmal kinesigenic dyskinesia (PKD) is a kind of nervous system disease characterized by paroxysmal involuntary movements induced by sudden movements. Neuroimaging studies have found that there are structural changes or abnormal functional connectivity in the basal ganglia, thalamus, cortex and other brain regions in PKD patients. The weakened inhibitory and regulatory function of the basal ganglia to the thalamus or the dysfunction of the thalamus itself may cause over⁃activation of the cortical region, resulting in involuntary movements. Recent studies have found that abnormal cerebellar function plays an important role in the pathogenesis of PKD, and abnormal cerebellar cortex can affect its normal inhibitory effect on deep cerebellar nuclei, also leading to excessive activation of thalamic⁃cortical pathway. This paper reviewed the mechanism and research progress of PKD in recent years, mainly focusing on the basal ganglia⁃thalamic⁃cortical circuit and the cerebellar⁃thalamic⁃cortical circuit, so as to improve clinicians' understanding of the pathogenesis of movement disorders.

Vertigo and dizziness are common clinical symptoms. Although most patients have a good prognosis, vascular vertigo and dizziness can have catastrophic consequences if not recognized promptly. At present, vascular dizziness and vertigo are still very significant problems in clinical missed diagnosis, diagnosis generalization and over examination. The publication of the international "Vascular vertigo and dizziness: diagnostic criteria" provides a basis for clinicians' diagnosis and treatment behavior. However, in practical clinical work, clinicians might have to deal with more complicated situations. This paper reviews the progress of clinical diagnosis of vascular vertigo and dizziness from the aspects of clinical features, imaging and laboratory examination, so as to provide a basis for the clinical diagnosis and treatment of vascular vertigo and dizziness as well as the construction of a more accurate prediction model.

Functional neurological disorder (FND) is a disorder of the autonomic motor or sensory system with well⁃defined symptoms, which covers functional movement disorder, psychogenic non⁃epileptic seizures, functional sensory disorder, functional cognitive disorder, persistent postural perceptual dizziness and so on. Its complex and diverse characteristics make the diagnosis and treatment of the disease and research difficult, so FND has long been a "gray area", but its high incidence, disability rate and high consumption of medical resources remind us that FND cannot be ignored. This paper reviews the current clinical classification of FND and the diagnostic criteria in order to improve the diagnosis and treatment by domestic colleagues.

Functional neurological disorder (FND) is a neuropsychiatric disorder characterized by the presence of neurological symptoms in the absence of any neurological abnormality that can be linked to a known pathology. There is currently limited research available regarding diagnosis and treatment of FND in children and adolescents. Pediatricians and neurologists have insufficient understanding of the disease. Patients have often been misdiagnosed, correctly diagnosed after lengthy delays, or lead to inappropriate treatments. This paper reviews the pertinent clinical and historical features, diagnostic criteria, and multi⁃disciplinary management of FND in the pediatric population, in order to improve clinical understanding of the disease as well as its diagnosis and treatment.

Medical artificial intelligence (AI) applies AI technology to the medical field to meet clinical needs, combines with the experience of doctors, and relies on the computing, analysis and decision⁃making ability of AI to provide accurate intelligent assistance for clinical diagnosis and treatment. At present, medical AI is based on knowledge guided and data driven approaches, but each has its own advantages and disadvantages. Combining knowledge⁃guided AI with data⁃driven AI and utilizing their respective advantages is expected to break through the application bottle neck of medical AI and promote the development and innovation of medical AI. This paper summarizes the application of medical AI driven by knowledge guidance and data mining and looks forward to the future development direction, in order to promote the innovation and application of AI technology in the medical field.

With the rapid development of artificial intelligence (AI), machine learning (ML) algorithms has been widely used in stroke diagnosis, treatment and prognosis, and has shown great application potential. This paper summarizes the application status of ML algorithms in stroke research from the aspects of ML algorithms research, ML algorithms in stroke diagnosis and classification diagnosis, outcome prediction, risk factor identification and so on, and looks into the future development direction.

With the development of the combination of medicine and engineering and the improvement of clinical rehabilitation demand, intelligent upper limb rehabilitation robots can provide stroke patients with high intensity and repetition of active rehabilitation training to restore the upper limb motor function and achieve the remodeling of damaged brain nerves. However, many upper limb rehabilitation robot systems are still in the stage of laboratory development or clinical verification. This paper summarizes the latest research results of upper limb rehabilitation robots at home and abroad, compares the advantages and disadvantages of different types of robots, looks forward to the development trend of upper limb rehabilitation robots, and provides ideas for further promoting clinical transformation.

With the rapid development of artificial intelligence (AI) technology, especially the application of deep learning (DL), the detection and quantitative evaluation of typical imaging markers of small cerebral vascular disease (CSVD) has been accelerated and the accuracy has been improved. In recent years, it has attracted much attention in the field of medical imaging. This paper intends to summarize the research progress and problems of deep learning in the imaging markers of CSVD such as cerebral microbleeds (CMBs), white matter hyperintensities (WMH), enlarged perivascular space (EPVS), lacunes, recent small subcortical infarcts (RSSI) and cerebral atrophy, so as to provide support for the precise treatment of CSVD.